Startseite The role of mean platelet volume in predicting thrombotic events
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The role of mean platelet volume in predicting thrombotic events

  • Yucel Colkesen EMAIL logo und Haldun Muderrisoglu
Veröffentlicht/Copyright: 24. November 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Studies on platelet function have accelerated and gained popularity since the advent of novel treatment modalities and techniques on atherosclerotic vascular disease, such as antiplatelet drugs and stents. Today it is widely known that platelets exert a fundamental role in inflammation in addition to their long known role in homeostasis and thrombotic events. Interaction with endothelial cells and leukocytes mediates inflammation, contributes to atherogenesis and modulates immune activity. Platelet activation which is a central factor in many arterial disorders may be triggered by multiple pathways. Platelet activation is shown as forming a larger shape, aggregation and releasing various active contents. Mean platelet volume is a marker of platelet size, function and activation. Increased mean platelet volume is shown by active and large platelets that release more thromboxane A2 than smaller ones. The aim of this review is to determine whether early detection of platelet activation via increased mean platelet volume would help to recognize the pro-inflammatory state and administer appropriate and effective treatment properly. An easily detectable marker by using a prompt and functional technique would help our approach to inflammation caused by platelets.


Corresponding author: Yucel Colkesen, MD, FESC, Associate Professor, Department of Cardiology, Baskent University, Faculty of Medicine, Dadaloglu mh. 39 sk., No. 6 Yuregir, Adana, 01250 Turkey Phone: +90-5334795944, Fax: +90-32232712798

Received: 2011-9-9
Accepted: 2011-11-10
Published Online: 2011-11-24
Published in Print: 2012-04-01

©2012 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. A sensitive quantitative test strip based point-of-care albuminuria screening assay
  2. Editorials
  3. Serum biomarkers for the non-invasive diagnosis of liver fibrosis: the importance of being validated
  4. Primary blood tubes mixing: time for updated recommendations
  5. Reviews
  6. 10.1515/cclm-2011-0847
  7. The hCG assay or pregnancy test
  8. Mini Reviews
  9. The role of mean platelet volume in predicting thrombotic events
  10. The role of red blood cell distribution width in cardiovascular and thrombotic disorders
  11. Genetics and Molecular Diagnostics
  12. Comparison of different collection procedures and two methods for DNA isolation from saliva
  13. Detection of α-globin gene deletion and duplication using quantitative multiplex PCR of short fluorescent fragments
  14. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR
  15. General Clinical Chemistry and Laboratory Medicine
  16. Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?
  17. Serum cystatin C is an early biomarker for assessment of renal function in burn patients
  18. 10.1515/cclm.2011.0849
  19. Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study
  20. Percentage of hypochromic erythrocytes as a potential marker of iron availability
  21. Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
  22. Validation and Outcome Studies
  23. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C
  24. Cancer Diagnostics
  25. Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients
  26. Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer
  27. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients
  28. Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
  29. Cardiovascular Diseases
  30. The performance of high sensitivity troponin for the diagnosis of acute myocardial infarction is underestimated
  31. The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: a meta-analysis
  32. Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis
  33. Letters to the Editor
  34. Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin I
  35. Evaluation of the interference by homogentisic acid and other organic acids on the enzymatic and Jaffé method creatinine assay
  36. A comparative analysis of the Iris iQ200 with manual microscopy as a diagnostic tool for dysmorphic erythrocytes in urine
  37. Falsely decreased ionized calcium results due to analytical interference by teriflunomide, the active metabolite of leflunomide (Arava®)
  38. Is polyethylene glycol precipitation of hyperprolactinaemic samples required when using the Beckman Coulter DxI-800 prolactin assay?
  39. Congress Abstracts
  40. ISMD2012: Ninth International Symposium on Molecular Diagnostics
  41. ArabMedLab Marrakech 2012
  42. Masthead
  43. Masthead
Heruntergeladen am 5.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.806/html
Button zum nach oben scrollen